Matthew Walls, Chief Executive Officer at Genedrive, holds 11.76M shares in GENinCode UK Ltd. (Ticker: GB:GENI), holds 1.52M shares in MyHealthChecked PLC (Ticker: GB:MHC), holds 13.77K shares in Genedrive (Ticker: GB:GDR). Most recently, Matthew Walls Bought ― shares of GENinCode UK Ltd. on Dec 22, 2023 for an estimated value of 50.00K.
What is the percentage of profitable transactions made by Matthew Walls?
The percentage of profitable transactions made by Matthew Walls is 25%.
What is the average return per transaction made by Matthew Walls?
The average return per transaction made by Matthew Walls is -28.10%.
What stocks does Matthew Walls hold?
Matthew Walls holds: GB:GDR, GB:MHC, GB:GENI stocks.
What was Matthew Walls’s latest transaction?
Matthew Walls latest transaction was an Informative Buy of 50.00K.
What was Matthew Walls's most profitable transaction?
Matthew Walls’s most profitable transaction was an Informative Buy of GB:GENI stock on December 22, 2023. The return on the trade was 28.50%.
What is Matthew Walls's role in Genedrive?
Matthew Walls's role in Genedrive is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.